Kb Financial Partners, LLC Novartis Ag Transaction History

Kb Financial Partners, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 16, 2023	BUY	$80.03 - $92.81 $27,610 - $32,019	345 Added 4.24%	8,475 $780,000
Q4 2022 Feb 17, 2023	SELL	$75.55 - $92.52 $52,280 - $64,023	-692 Reduced 7.84%	8,130 $738,000
Q3 2022 Nov 14, 2022	BUY	$74.61 - $87.26 $105,125 - $122,949	1,409 Added 19.01%	8,822 $671,000
Q2 2022 Aug 11, 2022	BUY	$80.52 - $93.75 $563,962 - $656,625	7,004 Added 1712.47%	7,413 $627,000
Q1 2022 May 17, 2022	SELL	$80.11 - $90.62 $640 - $724	-8 Reduced 1.92%	409 $36,000
Q4 2021 Feb 18, 2022	BUY	$79.7 - $88.13 $33,234 - $36,750	417 New	417 $36,000
Q3 2021 Nov 16, 2021	SELL	$81.78 - $95.14 $47,923 - $55,752	-586 Closed	0 $0
Q2 2021 Aug 17, 2021	BUY	$85.24 - $94.15 $3,239 - $3,577	38 Added 6.93%	586 $53,000
Q1 2021 Jun 08, 2021	BUY	$83.5 - $98.47 $45,758 - $53,961	548 New	548 $47,000

1,437

131M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $212B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Kb Financial Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Kb Financial Partners, LLC with notifications on news.